• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

3 Reasons Why Caribou Biosciences Is a Screaming Buy in July and Beyond

cafead

Administrator
Staff member
  • cafead   Jul 28, 2023 at 10:52: AM
via
  • Caribou's cell therapy programs are among the most advanced that exist.
  • So far, they also appear to be relatively safe and quite effective.
  • The company has more than enough money to reach its next clinical milestones.

article source
 

<